Edwards Lifesciences (EW) Other Operating Expenses (2017 - 2026)

Edwards Lifesciences' Other Operating Expenses history runs 5 years deep, the most recent figure standing at $14.2 million for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 25.65% year-over-year to $14.2 million; the TTM figure through Mar 2026 stood at $62.3 million (up 221.13% YoY), while the FY2025 annual figure was $67.2 million, up 22300.0% from the prior year.
• Other Operating Expenses was $14.2 million for Q1 2026 at Edwards Lifesciences, down from $14.3 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $22.7 million in Q4 2024 to a low of -$22.4 million in Q3 2024.
• Historically, Other Operating Expenses has averaged $11.7 million across 3 years, with a median of $14.3 million in 2025.
• Biggest YoY gain for Other Operating Expenses was 155.8% in 2025; the steepest drop was 37.0% in 2025.
• A 3-year view of Other Operating Expenses shows it stood at $22.7 million in 2024, then plunged by 37.0% to $14.3 million in 2025, then slipped by 0.7% to $14.2 million in 2026.
• The last three Other Operating Expenses figures came in at $14.2 million (Q1 2026), $14.3 million (Q4 2025), and $12.5 million (Q3 2025), per Business Quant data.